Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial
Gantenerumab 或 Solanezumab 对显性遗传性阿尔茨海默病下游生物标志物的影响:DIAN-TU-001 随机临床试验
期刊:Jama Neurology
影响因子:21.3
doi:10.1001/jamaneurol.2024.0991
Wagemann, Olivia; Liu, Haiyan; Wang, Guoqiao; Shi, Xinyu; Bittner, Tobias; Scelsi, Marzia A; Farlow, Martin R; Clifford, David B; Supnet-Bell, Charlene; Santacruz, Anna M; Aschenbrenner, Andrew J; Hassenstab, Jason J; Benzinger, Tammie L S; Gordon, Brian A; Coalier, Kelley A; Cruchaga, Carlos; Ibanez, Laura; Perrin, Richard J; Xiong, Chengjie; Li, Yan; Morris, John C; Lah, James J; Berman, Sarah B; Roberson, Erik D; van Dyck, Christopher H; Galasko, Douglas; Gauthier, Serge; Hsiung, Ging-Yuek R; Brooks, William S; Pariente, Jérémie; Mummery, Catherine J; Day, Gregory S; Ringman, John M; Mendez, Patricio Chrem; St George-Hyslop, Peter; Fox, Nick C; Suzuki, Kazushi; Okhravi, Hamid R; Chhatwal, Jasmeer; Levin, Johannes; Jucker, Mathias; Sims, John R; Holdridge, Karen C; Proctor, Nicholas K; Yaari, Roy; Andersen, Scott W; Mancini, Michele; Llibre-Guerra, Jorge; Bateman, Randall J; McDade, Eric